1. Home
  2. Blogs for July, 2020

Month: July 2020

Hamilton Lane holds final close for its new Impact Fund

Hamilton Lane, a private markets asset management firm, has held the final close of its new Impact Fund, pulling in over $95m.

Cirque du Soleil Gets Stalking Horse

In response to the disruption and forced show closures as a result of the COVID-19 pandemic, Cirque du Soleil Entertainment Group has filed for protection from creditors in Canada – under the Companies’ Creditors Arrangement

Webster and MedEquity Expand BelMar

Belmar Pharmacy, a compounding pharmacy and a portfolio company of Webster Equity Partners and MedEquity Capital, has acquired APS Pharmacy. Compounding pharmacies combine, mix, or alter one or more ingredients to create a medication that

New Water Forms Emerald EMS

New Water Capital has merged two of its portfolio companies – DataED and Bestronics – to form Emerald EMS. New Water acquired DataED and Bestronics – two Tier III manufacturers that provide high-mix, low/medium-volume printed

Datasite: AI to Speed Up M&A

According to Datasite, over the next five years new technologies, including artificial intelligence, will transform the mergers and acquisitions process by decreasing the time it takes to perform due diligence to less than a month

Hamilton Lane closes its first impact fund at $95m

The vehicle seeks to make primary or secondary investments in private market strategies, including buyout, growth, venture capital, and real assets

Turnaround specialist Alteri rescues UK retailer Bensons for Beds

Sister company Harveys will continue to trade in administration

Elysian Capital holds £270m first close for third fund

The fund, which has a £300m target, will focus on making majority-stake investments in lower middle-market companies in the UK and Ireland

KKR appoints senior adviser for support European portfolio management

Adam Warby will advise portfolio company management teams in the technology arena

New York-based Arsenal to acquire Britain’s Cello in take-private deal

At a cash price of 161p per share, the takeover offer represents a premium of 43.8% to the closing share price of Cello on 30 June

HV Holtzbrinck leads €60m round for SolarisBank

HV Holtzbrinck Ventures has led a €60m round for Germany-based banking startup SolarisBank.

Disruption from COVID-19 hits ASEAN private equity hard

Opalesque Industry Update - After a strong 2019, the ASEAN private equity industry has been shaken by the outbreak of the COVID-19 pandemic, reports Preqin. As of September 2019 (the latest data available), ASEAN-focused private

PE-backed Mercell prepares for IPO

Viking Venture-backed Mercell, a supplier of digital bidding and procurement tools based in northern Europe, has announed plans for an IPO.

Gryphon takes majority stake in Microsoft Azure advisory, services provider 3Cloud

San Francisco private equity house Gryphon Investors has completed a majority investment in Microsoft Azure cloud platform advisory and technical services provider 3Cloud.

FII-backed Seco to list on the Italian stock exchange

Seco, an Italy-based computer components producer baceked by Fondo Italiano d'Investimento (FII), plans to list on the Italian Stock Exchange in 2021.

Committed Capital invests in MR Marine Group

Committed Capital has acquired a majority stake in Netherlands-headquartered maritime service MR Marine Group.

Innvotec launches Female Ventures Fund

Alternative investment fund manager Innvotec has launched Female Ventures Fund (FVF) to invest exclusively in UK female-founded or co-founded enterprises.

Huge confidence from insurers that asset managers can navigate coronavirus crisis – State Street survey

Asset managers have been given a massive vote of confidence from insurers, with the vast majority confident their investment managers can navigate the current financial crisis caused by COVID-19, new research reveals.

EQT leads $3m seed round for Willa

Swedish finanical technology startup Willa has raised $3m in a seed round led by EQT Ventures.

Freeline closes $120m extended series-C round

Freeline, a British clinical-stage biotechnology company, has closed a $120m extended series-C financing. The round was led by Novo Holdings, Eventide Asset Management and Wellington Management Company.

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.